Evidence brief · Supplement

Inositol (Myo-Inositol) for Gestational diabetes prevention

Evidence grade C — Emerging

Overall grade
Grade C
Last revised
1
graded outcome
0
references listed

Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.

1 at grade C — 1 graded row

What is known

Each outcome with its grade (how strong the evidence is, A to D), the size of the effect where the entry records one, and how often studies agree.

  • Gestational diabetes preventionEvidence grade C

    Emerging

    Smallmixed

What is uncertain

Read off the same rows as above. Nothing here is added that the entry does not itself record.

  • Thin evidence: Gestational diabetes prevention (grade C).

The evidence in words

The verdict

For gestational diabetes prevention, Inositol (Myo-Inositol) earns evidence grade C (small effect, mixed consistency) — the evidence is limited or mixed. Emerging

How it might work

It acts as a second messenger for insulin and serotonin/other receptors, improving insulin sensitivity and modulating mood pathways.

How to use it

2–4 g/day myo-inositol for PCOS (often a 40:1 myo:D-chiro ratio); higher doses (up to ~18 g) in psychiatric trials.

Safety & cautions

Very well tolerated; mild GI upset at high doses.

Bottom line

A standout for PCOS metabolic and ovulatory support, with a useful anxiety/OCD sideline. 2–4 g/day; well tolerated.

How it is used

As the entry records it, from the studies it summarises. Not a recommendation for you — doses that suit a trial population may not suit you.

PCOS
2–4 g/day myo-inositol (40:1 with D-chiro).

Goes with

Entries that share this one's tags or conditions.

Sources

This entry lists no references of its own — it is assembled from the entries it links to, whose sources are on their pages.

Last revised . A grade is this entry's reading of the evidence, not medical advice.